Issue Date Jul 7, 2022
Claim this applicationPatent Application - COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR > Summary
US Patent Application
Patent Application No. US 20220211696
Published on Jul 7, 2022
Application No. 17/395366
Filed on Aug 5, 2021
Priority Date -
Inventor/Applicants
7Sampath, Deepak - South San Francisco, CA US
Klein, Christian - Iffeldorf, DE
Fairbrother, Wayne John - South San Francisco, CA US
Enschede, Sari L. Heitner - River Forest, IL US
Humerickhouse, Rod A. - Highland Park, IL US
Roberts, Andrew W. - Melbourne, Victoria, AU
Seymour, John F. - Melbourne, Victoria, AU
Classification
International:
A61K 31/496